Sirolimus as an Effective Agent in the Treatment of Immune Thrombocytopenia (ITP) and Evans Syndrome (ES): A Single Institution’s Experience - Concepedia

Concepedia

Publication | Closed Access

Sirolimus as an Effective Agent in the Treatment of Immune Thrombocytopenia (ITP) and Evans Syndrome (ES): A Single Institution’s Experience

43

Citations

10

References

2017

Year

Sylwia Jasinski, Mark E. Weinblatt, Chana L. Glasser

Journal of Pediatric Hematology/Oncology

Abstract

Our data suggest that sirolimus is a safe and effective steroid-sparing agent in the treatment of persistent ITP and ES.

References

	Year	Citations

Page 1